Evolus EOLS
NASDAQ EOLS
$6.67 -0.31 (-4.44%)
As of: Nov 10, 2026 · 1:51 PM EST

Evolus (EOLS) Gross Margin (2019 - 2026)

Updated

Evolus (EOLS) posted Gross Margin of 65.02% for Q3 2026, down 1.45 percentage points from 66.47% a year earlier and down 2.98 percentage points from the prior quarter.

Analysis

Evolus (EOLS) Gross Margin (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Gross Margin at Evolus was 66.38%, down 0.25 percentage points year-over-year; for FY2025, it came in at 66.33%, down 2.14 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of -1.31 percentage points (FY2020 to FY2025).
  • In prior years, Evolus' Gross Margin was 68.46% in FY2024 (+0.39 pp), 68.08% in FY2023 (+7.67 pp), 60.41% in FY2022 (+4.08 pp) and 56.32% in FY2021 (-11.31 pp).
  • The Q3 2026 figure stands as the lowest quarterly Gross Margin since Q4 2023.
  • On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of -0.69 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2023, with a gain of 12.75 percentage points; the weakest was Q4 2021, with a drop of 10.32 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 68.00% (Q2 2026), 66.86% (Q1 2026) and 65.66% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 68.12%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 75.38%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 72.95%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 78.02%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 83.60%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 73.10%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 81.07%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 75.71%
10 Evolus 455.33 Mn 264.84 Mn 50.69 Mn 65.02%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 65.02%
Jun 30, 2026 68.00%
Mar 31, 2026 66.86%
Dec 31, 2025 65.66%
Sep 30, 2025 66.47%
Jun 30, 2025 65.31%
Mar 31, 2025 68.09%
Dec 31, 2024 66.67%
Sep 30, 2024 68.92%
Jun 30, 2024 70.35%
Mar 31, 2024 68.26%
Dec 31, 2023 63.56%
Sep 30, 2023 69.15%
Jun 30, 2023 70.19%
Mar 31, 2023 70.89%
Dec 31, 2022 62.60%
Sep 30, 2022 60.21%
Jun 30, 2022 57.43%
Mar 31, 2022 61.05%
Dec 31, 2021 54.31%
API Access

Evolus Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY